Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.28 | €174.43 | 16.850% |
| Insmed Inc. | 16 | 1 | 4 | 0 | €23.60 | €44.01 | 86.469% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Atossa Genetics Inc | 6 | 1 | 3 | 0 | €1.45 | €3.74 | 158.260% |
| Dentsply Sirona Inc. | 13 | 0 | 3 | 0 | €25.90 | €37.86 | 46.191% |
| Humana Inc. | 23 | 0 | 3 | 0 | €318.30 | €439.88 | 38.196% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.23 | €40.66 | 55.041% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.40 | €421.61 | 16.017% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.74 | €78.42 | 48.696% |
| MacroGenics Inc. | 11 | 1 | 3 | 1 | €4.11 | €12.42 | 202.451% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.90 | €196.74 | 40.626% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €199.25 | €207.72 | 4.249% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.90 | €87.81 | 9.895% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €44.49 | €41.54 | -6.642% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.35 | €50.33 | 24.740% |
| Select Medical Holdings | 6 | 0 | 3 | 0 | €31.20 | €36.41 | 16.688% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €24.00 | €68.78 | 186.580% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.46 | €26.01 | 33.640% |
| United Therapeutics | 18 | 0 | 3 | 0 | €249.20 | €288.66 | 15.835% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.60 | €20.43 | 76.142% |
| Centene Corp. | 15 | 0 | 3 | 0 | €71.48 | €82.57 | 15.516% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €73.72 | €102.62 | 39.201% |